NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Walvax Biotechnology Co. Ltd (SHE: 300142)

 
300142 Technical Analysis
5
As on 26th Jan 2026 300142 STOCK Price closed @ 14.48 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 11.78 & Strong Buy for SHORT-TERM with Stoploss of 12.52 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

300142STOCK Price

Open 13.33 Change Price %
High 14.65 1 Day 1.49 11.47
Low 12.99 1 Week 1.95 15.56
Close 14.48 1 Month 3.15 27.80
Volume 227641748 1 Year -0.25 -1.70
52 Week High 14.87 | 52 Week Low 9.89
 
SHE China Most Active Stocks
002131 8.00 -4.76%
000630 7.55 10.06%
000981 4.74 -5.58%
000725 4.47 0.45%
002195 9.98 -5.04%
300058 20.74 0.92%
002202 28.40 -3.99%
000100 5.03 -0.40%
300017 13.78 20.03%
000620 3.40 -5.82%
 
SHE China Top Gainers Stocks
300463 14.20 20.03%
300017 13.78 20.03%
300639 7.25 20.03%
300871 32.62 20.01%
300139 52.90 20.01%
300391 0.92 19.48%
300461 32.32 18.30%
300482 25.56 16.23%
300209 7.23 15.50%
300837 66.00 15.36%
 
SHE China Top Losers Stocks
300117 0.43 -20.37%
300044 5.62 -14.33%
300503 61.70 -13.89%
300123 7.36 -13.41%
300421 30.20 -13.27%
300280 0.33 -13.16%
300672 135.96 -12.85%
300108 0.21 -12.50%
300208 0.28 -12.50%
300526 0.56 -12.50%
 
 
300142
Daily Charts
300142
Intraday Charts
Whats New @
Bazaartrend
300142
Free Analysis
 
300142 Important Levels Intraday
RESISTANCE17.68
RESISTANCE16.65
RESISTANCE16.02
RESISTANCE15.38
SUPPORT13.58
SUPPORT12.94
SUPPORT12.31
SUPPORT11.28
 
300142 Forecast January 2026
4th UP Forecast17.74
3rd UP Forecast16.69
2nd UP Forecast16.05
1st UP Forecast15.4
1st DOWN Forecast13.56
2nd DOWN Forecast12.91
3rd DOWN Forecast12.27
4th DOWN Forecast11.22
 
300142 Weekly Forecast
4th UP Forecast16.33
3rd UP Forecast15.74
2nd UP Forecast15.37
1st UP Forecast15.00
1st DOWN Forecast13.96
2nd DOWN Forecast13.59
3rd DOWN Forecast13.22
4th DOWN Forecast12.63
 
300142 Forecast2026
4th UP Forecast24.92
3rd UP Forecast21.57
2nd UP Forecast19.5
1st UP Forecast17.43
1st DOWN Forecast11.53
2nd DOWN Forecast9.46
3rd DOWN Forecast7.39
4th DOWN Forecast4.04
 
 
300142 Other Details
Segment EQ
Market Capital 90415497216.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
300142 Address
300142
 
300142 Latest News
 
Your Comments and Response on Walvax Biotechnology Co. Ltd
 
300142 Business Profile
Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others. It provides Group A, C meningococcal polysaccharide conjugate vaccine for infants below or equal to 2 years preventing diseases, such as cerebrospinal meningitis and septicemia; Group A and C meningococcal polysaccharide vaccine for in adults and children over the age of 2 years and adults to prevent disease caused by the bacterium Neisseria meningitidis group A or group C; and Group ACYW135 meningococcal polysaccharide vaccine for children above 2 years old to prevent epidemic cerebrospinal meningitis caused by Neisseria meningitidis group A, C, Y, and W135. The company also offers haemophilus influenzae type b conjugate vaccine for children from the age of 2 months to 5 years for the prevention of infectious diseases, including meningitis, pneumonia, septicemia, cellulitis, arthritis, epiglottitis, etc. In addition, it provides diphtheria, tetanus, and acellular pertussis combined vaccine for the prevention of diphtheria, tetanus, and pertussis for individuals from the age of 3 months to 6 years; and 23-valent pneumococcal polysaccharide vaccine for children above 2 years old to prevent pneumococcal disease caused by 23 serotypes. Walvax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Kunming, China. Address: Building 9A, 19th Floor, Kunming, China, 650106
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service